Montana’s harsh climate, with low humidity and extreme temperatures, commonly exacerbates dry skin, especially in the wintertime. In susceptible individuals, dry skin may manifest as eczema flares, ...
Tralokinumab is effective for the treatment of AD through 72 weeks across body regions, including the head/neck, trunk, and limbs.
ZORYVE ® (roflumilast) foam 0.3% is a once-daily, steroid-free, leave-in topical foam uniquely formulated to treat the itching, redness, and flaking of seborrheic dermatitis anywhere it appears, ...
HORSHAM, PA — STRATA Skin Sciences Inc. (Nasdaq: SSKN) said Johns Hopkins Dermatology has added the company’s XTRAC 308 nm ...
Ruxolitinib phosphate cream was approved for marketing by the NMPA in January 2026, becoming the first and only targeted drug approved in China for the treatment of vitiligo. The acceptance of this ...
The start of 2026 has been a period of strong execution and momentum across our clinical programs, broadly, and with ATI-052 specifically,” said Dr. Jesse Hall, Chief Medical Officer of Aclaris. “The ...
Studies have demonstrated a critical role of the cytokines thymic stromal lymphopoietin (TSLP), IL-33, and IL-25, produced by epithelial and other cells at mucosal surfaces in response to a wide range ...
Emerging evidence supports the skin microbiome as a promising avenue for precision medicine in the treatment of dermatologic ...
About Celldex Celldex is pioneering new horizons in immunology to deliver life-changing therapies. We are relentless in our pursuit of novel antibody-based treatments that engage the human immune ...
If your current eczema routine only offers temporary relief, it may be time for a change. Learn how to address underlying inflammation and find a treatment that fits your busy lifestyle.
Right now, Regeneron is trading for 17x forward earnings estimates, down from more than 25x in the second half of 2024.
Citi's 2026 Virtual Oncology Leadership Summit February 19, 2026 2:30 PM ESTCompany ParticipantsRafael Amado - President and Head ...